Disease Narrative for HIV
FAQ – Financial Guidelines
Hepatitis C diagnostics technology landscape – May 2019
Cervical cancer. Screening and treatment of pre-cancerous lesions for secondary prevention of cervical cancer
The state of the malaria RDT market 2018
Unitaid audited financial report for the year ended 31 December 2018
Knowing your status – then and now. Realizing the potential of HIV self-testing, STAR Initiative Report
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Building for sustainability: Accelerating regional manufacturing for diagnostics (FIND and Unitaid)
Meeting report: Strengthening cooperation to enable sustainable development and manufacturing of effective, quality and affordable diagnostic countermeasures (FIND and Unitaid)
Q&A: Monoclonal antibodies
From milligrams to megatons: A climate and nature assessment of 10 key health products
Executive summary: From milligrams to megatons: A climate and nature assessment of 10 key health products
Landscape of rapid diagnostic tests for severe bacterial infections in advanced HIV Disease
The health products manufacturers support platform: Enhancing regional manufacturing of health technologies in Africa
Novel business models for accessible monoclonal antibodies for infectious diseases in LMICS: Multistakeholder meeting recommendations
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
Impact story: Improving use of tuberculosis diagnostics
Impact story: Improving severe malaria outcomes
Impact story: Accelerating access to seasonal malaria chemoprevention
Impact story: HIV Self-Testing
Impact story: Improved treatment for HIV: Dolutegravir
Impact story: Early-infant diagnosis of HIV using point-of-care technologies
Impact story: Medicines Patent Pool
Impact story: Childhood tuberculosis
